Wealthcare Advisory Partners’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,753
| Closed | -$325K | – | 1162 |
|
|
2026
Q1 | $325K | Sell |
2,753
-2,154
| -44% | -$266K | 0.01% | 849 |
|
|
2025
Q4 | $617K | Sell |
4,907
-18
| -0.4% | -$2.35K | 0.01% | 629 |
|
|
2025
Q3 | $721K | Buy |
4,925
+947
| +24% | +$143K | 0.02% | 580 |
|
|
2025
Q2 | $620K | Sell |
3,978
-328
| -8% | -$52K | 0.01% | 594 |
|
|
2025
Q1 | $709K | Buy |
4,306
+9
| +0.2% | +$1.5K | 0.02% | 509 |
|
|
2024
Q4 | $700K | Sell |
4,297
-63
| -1% | -$11.3K | 0.02% | 500 |
|
|
2024
Q3 | $852K | Sell |
4,360
-262
| -6% | -$48.3K | 0.02% | 457 |
|
|
2024
Q2 | $801K | Buy |
4,622
+219
| +5% | +$36.4K | 0.03% | 443 |
|
|
2024
Q1 | $745K | Buy |
4,403
+39
| +0.9% | +$7.3K | 0.02% | 455 |
|
|
2023
Q4 | $861K | Sell |
4,364
-207
| -5% | -$36.6K | 0.03% | 354 |
|
|
2023
Q3 | $795K | Sell |
4,571
-105
| -2% | -$19.1K | 0.04% | 319 |
|
|
2023
Q2 | $805K | Buy |
4,676
+61
| +1% | +$10.5K | 0.04% | 336 |
|
|
2023
Q1 | $768K | Sell |
4,615
-15
| -0.3% | -$2.46K | 0.03% | 348 |
|
|
2022
Q4 | $679K | Buy |
4,630
+229
| +5% | +$33.9K | 0.03% | 349 |
|
|
2022
Q3 | $653K | Buy |
4,401
+372
| +9% | +$62.2K | 0.04% | 302 |
|
|
2022
Q2 | $692K | Sell |
4,029
-18
| -0.4% | -$3.11K | 0.04% | 260 |
|
|
2022
Q1 | $763K | Buy |
4,047
+7
| +0.2% | +$1.38K | 0.05% | 233 |
|
|
2021
Q4 | $986K | Buy |
4,040
+197
| +5% | +$43.1K | 0.06% | 197 |
|
|
2021
Q3 | $746K | Buy |
3,843
+52
| +1% | +$10.5K | 0.05% | 239 |
|
|
2021
Q2 | $706K | Buy |
3,791
+39
| +1% | +$6.77K | 0.05% | 248 |
|
|
2021
Q1 | $591K | Buy |
3,752
+466
| +14% | +$73.8K | 0.04% | 259 |
|
|
2020
Q4 | $544K | Buy |
3,286
+41
| +1% | +$6.67K | 0.05% | 227 |
|
|
2020
Q3 | $537K | Buy |
3,245
+2
| +0.1% | +$307 | 0.06% | 190 |
|
|
2020
Q2 | $444K | Buy |
3,243
+122
| +4% | +$15.9K | 0.06% | 190 |
|
|
2020
Q1 | $367K | Buy |
3,121
+72
| +2% | +$9.48K | 0.05% | 191 |
|
|
2019
Q4 | $404K | Buy |
3,049
+2,859
| +1,505% | +$355K | 0.05% | 198 |
|
|
2019
Q3 | $24K | Hold |
190
| – | – | ﹤0.01% | 708 |
|
|
2019
Q2 | $22K | Hold |
190
| – | – | ﹤0.01% | 703 |
|
|
2019
Q1 | $19K | Hold |
190
| – | – | ﹤0.01% | 682 |
|
|
2018
Q4 | $16K | Hold |
190
| – | – | ﹤0.01% | 692 |
|
|
2018
Q3 | $17K | Hold |
190
| – | – | ﹤0.01% | 727 |
|
|
2018
Q2 | $16K | Buy |
190
+37
| +24% | +$3.12K | ﹤0.01% | 729 |
|
|
2018
Q1 | $13K | Sell |
153
-14
| -8% | -$1.1K | ﹤0.01% | 679 |
|
|
2017
Q4 | $12K | Buy |
167
+13
| +8% | +$893 | ﹤0.01% | 646 |
|
|
2017
Q3 | $10K | Buy |
+154
| New | +$9.65K | ﹤0.01% | 555 |
|
Other funds holding ZTS
MBI
SI
MIHAS
FFM
CIM
SIM
DLA
Wealthcare Advisory Partners's ZTS Position: Q2 2026 in Review
Wealthcare Advisory Partners sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,753 shares — an estimated $325K sold.
Wealthcare Advisory Partners first reported a position in ZTS in Q3 2017 and held it in 35 quarters. The position peaked at $986K in Q4 2021. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Wealthcare Advisory Partners reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
- Wealthcare Advisory Partners sold 2,753 Zoetis shares in Q2 2026, an estimated $325K.
- Wealthcare Advisory Partners first reported a position in Zoetis in Q3 2017 and held it in 35 quarters.
- Wealthcare Advisory Partners's Zoetis position peaked at $986K in Q4 2021.
- 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.